Literature DB >> 20583256

Hepatocyte growth factor induces invasion and migration of ovarian cancer cells by decreasing the expression of E-cadherin, beta-catenin, and caveolin-1.

Jun Hu1, Shujuan Shao, Yang Song, Jinyao Zhao, Yan Dong, Linlin Gong, Peiman Yang.   

Abstract

Distant metastases are unusual occurrences at presentation and during the progression of epithelial ovarian cancer. There are no good clinical predictors of this phenomenon. In this study, we examined the role of hepatocyte growth factor (HGF) in cell metastasis in ovarian cancer HO8910 cells. We found that HGF has functions in biological processes essential to metastasis, including morphological remodeling, invasion and migration (P = 0.000, P = 0.001). Western blotting showed that in HGF treated group, the expression of E-cadherin, beta-catenin, and caveolin-1 was decreased as compared with the control group (P = 0.000, P = 0.002, P = 0.000). Immunofluorescence staining demonstrated that the population of E-cadherin, beta-catenin, and caveolin-1 at the cell membrane was downregulated. Reverse transcriptase polymerase chain reaction analysis revealed the decreased expression of E-cadherin, beta-catenin, and caveolin-1 at the mRNA level. Our data indicated that HGF leads to downregulation of E-cadherin, beta-catenin, and caveolin-1, disassembly of cell-cell contacts, and invasion and migration enhancement in human ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583256     DOI: 10.1002/ar.21147

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  18 in total

1.  Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.

Authors:  Ruobing Leng; Gang Liao; Haixia Wang; Jun Kuang; Liangdan Tang
Journal:  Med Oncol       Date:  2015-01-14       Impact factor: 3.064

2.  Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.

Authors:  Wei Tian; Guowen Wang; Jilong Yang; Yi Pan; Yulin Ma
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

3.  Absence of caveolin-1 alters heat shock protein expression in spontaneous mammary tumors driven by Her-2/neu expression.

Authors:  Daniel R Ciocca; F Darío Cuello-Carrión; Anthony L Natoli; Christina Restall; Robin L Anderson
Journal:  Histochem Cell Biol       Date:  2011-11-15       Impact factor: 4.304

4.  2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Authors:  Lokesh Dalasanur Nagaprashantha; Rit Vatsyayan; Jyotsana Singhal; Poorna Lelsani; Laszlo Prokai; Sanjay Awasthi; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

5.  Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.

Authors:  Wenbin Kuang; Qiuchan Deng; Chuntao Deng; Wensheng Li; Shaowei Shu; Meirong Zhou
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

6.  Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.

Authors:  N M Ayoub; M R Akl; P W Sylvester
Journal:  Cell Prolif       Date:  2013-08-23       Impact factor: 6.831

7.  UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

Authors:  Guoyi Wu; Nan Lin; Linan Xu; Bo Liu; Mark A Feitelson
Journal:  BMC Cancer       Date:  2013-03-28       Impact factor: 4.430

8.  Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy.

Authors:  Mariusz Z Ratajczak; Tomasz Jadczyk; Gabriela Schneider; Sham S Kakar; Magda Kucia
Journal:  J Ovarian Res       Date:  2013-12-27       Impact factor: 4.234

Review 9.  Caveolin-1 as a promoter of tumour spreading: when, how, where and why.

Authors:  Rebecca Senetta; Giulia Stella; Ernesto Pozzi; Niccolo Sturli; Daniela Massi; Paola Cassoni
Journal:  J Cell Mol Med       Date:  2013-03-23       Impact factor: 5.310

10.  Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer.

Authors:  Paul W Sylvester
Journal:  Clin Transl Med       Date:  2014-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.